Skip to main content
MedPathMedPath Home
Clinical Trials/PACTR201908919241847
PACTR201908919241847
Not yet recruiting
未知

An Investigation to Evaluate the Performance of the Cepheid Xpert® HIV-1 VL XC Test

Cepheid0 sites800 target enrollmentJuly 5, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHIV/AIDS

Overview

Phase
未知
Intervention
Not specified
Conditions
HIV/AIDS
Sponsor
Cepheid
Enrollment
800
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 5, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Cepheid

Eligibility Criteria

Inclusion Criteria

  • •18 years of age or older
  • •Able and willing to provide the required amount of blood without compromising their well being
  • •Able to understand the study and sign the informed consent
  • •Adults at risk for HIV infection as defined by WHO guidelines 5 and/or the individual is from a region with known high incidence of HIV infection
  • •Adults who have not been previously screened for HIV or that have been previously screened for HIV and were negative for HIV infection.

Exclusion Criteria

  • •Study participant previously tested positive for HIV infection
  • •Previously enrolled in this study.
  • •The Investigator does not feel the study participant is suitable to participate in this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Pivotal trial to evaluate an Artificial intelligence (AI) diabetic retinopathy grading classifier in the New Zealand population undergoing regular screening for diabetic retinopathy.DiabetesDiabetic retinopathyMetabolic and Endocrine - DiabetesEye - Diseases / disorders of the eye
ACTRN12620000488909Dr David Squirrell1,000
Suspended
Not Applicable
To compare the performance of RoboICSI with standard existing technique.
CTRI/2018/11/016300SPOVUM TECHNOLOGIES PRIVATE LIMITED
Not yet recruiting
Not Applicable
A study to evaluate the performance of the non-invasive hemodynamic monitor HemoVistaTM (BiLab Co. Ltd. Korea) and improve the algorithm in patients who underwent liver transplantation: a prospective observational study
KCT0009069Asan Medical Center80
Completed
Not Applicable
Study to evaluate the analytical performance of the Virax immune COVID-19 flow cytometry kitCOVID-19 testkitCOVID-19 coronavirus
NL-OMON51279Virax Biolabs Limited96
Completed
Not Applicable
Prospective study to investigate the performance of cytokine removal of polymethyl methacrylate hemofilters with two different membrane surface areaSevere sepsis, Septic shock
JPRN-UMIN000012164Department of Emergency and Critical Care Medicine, Chiba University, Graduate School of Medicine20